Holen Sie sich die Stockscreener-App
1.24
2.36%
-0.03
Handel nachbörslich:
1.23
-0.01
-0.81%
Schlusskurs vom Vortag:
$1.27
Offen:
$1.27
24-Stunden-Volumen:
1.28M
Relative Volume:
7.30
Marktkapitalisierung:
$51.94M
Einnahmen:
$9.16M
Nettoeinkommen (Verlust:
$-68.17M
KGV:
-0.7607
EPS:
-1.63
Netto-Cashflow:
$-80.16M
1W Leistung:
-12.68%
1M Leistung:
-8.82%
6M Leistung:
-15.65%
1J Leistung:
-25.97%
1-Tages-Spanne:
$1.20
$1.28
1-Wochen-Bereich:
$1.20
$1.38
52-Wochen-Spanne:
$0.9707
$1.94
Ikena Oncology Inc Stock (IKNA) Company Profile
Firmenname
Ikena Oncology Inc
Sektor
Branche
Telefon
857-343-8292
Adresse
50 NORTHERN AVE., BOSTON
Vergleichen Sie IKNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
1.24 | 59.48M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-09-22 | Eingeleitet | Wedbush | Outperform |
| 2023-05-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Jefferies | Buy |
| 2021-04-20 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ikena Oncology Inc Aktie (IKNA) Neueste Nachrichten
What analysts say about Ikena Oncology Inc. stockExplosive wealth accumulation - jammulinksnews.com
Ikena Oncology Announces Merger with Inmagene - TipRanks
IKNA issues special CVR dividend ahead of Inmagene merger | IKNA SEC FilingForm 8-K - Stock Titan
What drives Ikena Oncology Inc. stock priceBreakneck growth rates - jammulinksnews.com
Is Ikena Oncology Inc. a good long term investmentBreakthrough stock performance - jammulinksnews.com
Ikena Oncology Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com
Ikena Oncology Approves Merger and Reverse Stock Split - The Globe and Mail
Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting By Investing.com - Investing.com South Africa
Ikena Oncology amends executive agreement with Dr. Jotin Marango for equity vesting - Investing.com
Ikena Oncology Updates Employment Terms Amid Merger Plans - TipRanks
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire
How Ikena Oncology Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
Ikena Oncology announces stockholder approval of merger with Inmagene Biopharmaceuticals - MarketScreener
Ikena shareholders approve merger with Inmagene, reverse stock split - Investing.com Australia
Ikena announces 1-for-12 reverse stock split, approval of Inmagene merger - TipRanks
Ikena shareholders approve merger with Inmagene, reverse stock split By Investing.com - Investing.com Nigeria
Ikena Oncology Approves Merger with Inmagene Biopharmaceuticals - AInvest
Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan
Why Ikena Oncology Inc. stock attracts strong analyst attentionFree Best Performing Stock Alerts - Newser
What makes Ikena Oncology Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
Ikena Oncology Merger Recommended by Shareholder Services - The Globe and Mail
SBET spends $25.7M on 10,000 ETH; Share-reserve waiver opens ATM issuances | IKNA SEC FilingForm 8-K - Stock Titan
Ikena Oncology Announces Support from ISS and Glass Lewis for Shareholder Vote on Inmagene Merger - Nasdaq
Ikena Oncology Announces ISS and Glass Lewis Recommend - GlobeNewswire
Ikena Oncology (NASDAQ:IKNA) Stock Price Up 1.5% – Here’s Why - Defense World
Ikena Oncology: Inmagene Begins Phase 2b Study for IMG-007 - TipRanks
Two Sigma Investments LP Sells 55,935 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Squarepoint Ops LLC Acquires Shares of 43,640 Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Millennium Management LLC Trims Stake in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Citadel Advisors LLC Lowers Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Two Sigma Advisers LP Has $258,000 Stock Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Acquires New Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology Reports Q1 Loss Amid Merger Plans - TipRanks
Ikena Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Ikena Oncology, Inc. SEC 10-Q Report - TradingView
Renaissance Technologies LLC Sells 70,400 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Geode Capital Management LLC Purchases 56,936 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Marquis Who's Who Honors Wilmin P. Bartolini for Expertise in Pharmaceutical Consulting - 24-7 Press Release Newswire
Prudential Financial Inc. Trims Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges - Investing.com Canada
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges By Investing.com - Investing.com South Africa
Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):